Peter Lin

3.6k citations
42 papers · 1.8k · 5 hit papers · h-index 17

Impact in

Papers in

Peter Lin

41 papers receiving 1.7k citations

Peter Lin's Hit Papers

Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial 2025 · 37 citations
370+1+3Years since publication250500750

Peers

Peter Lin
Comparison fields: 5 of 49
  • Radiology, Nuclear Medicine and Imaging 1.2k
  • Otorhinolaryngology 169
  • Pulmonary and Respiratory Medicine 693
  • Radiation 59
  • Oncology 55
Replace Sheila Rege with:
Sheila Rege United States
Maarten L. Donswijk Netherlands
Martine Roelandts Belgium
Manabu Oguchi Japan
Sagus Sampath United States
Arndt‐Christian Müller Germany
Hinrich A. Wieder Germany
Thomas Hehr Germany
John C. Paschold United States
Shozo Okamoto Japan
Peter Lin relative to Sheila Rege United States Sheila Rege's profile →
Citations per field
00.5×50×100×153×
Sheila Rege · 1×
Citations per year

Countries citing papers authored by Peter Lin

Since Specialization
Citations

This map shows the geographic impact of Peter Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lin more than expected).

Fields of papers citing papers by Peter Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lin. The network helps show where Peter Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Lin Line = papers co-authored together Peter Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Hit paper breakdown →
2021853
2
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Hit paper breakdown →
2023160
3
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
Hit paper breakdown →
2024113
4
Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study
Hit paper breakdown →
202482
5 200877
6 201541
7 201741
8
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial
Hit paper breakdown →
202537
9 201127
10 201627
11 201626
12 201524
13 200020
14 202519
15 201018
16
Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET.
200717
17 201617
18 201916
19 201414
20 201614

About Peter Lin

Peter Lin is a scholar working on Radiology, Nuclear Medicine and Imaging, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiation, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (15 papers), Head and Neck Cancer Studies (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Prostate Cancer Treatment and Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Diagnosis and Treatment (2 papers), MRI in cancer diagnosis (2 papers) and Thyroid Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.2k citations), Otorhinolaryngology (169 citations), Pulmonary and Respiratory Medicine (693 citations), Radiation (59 citations) and Oncology (55 citations). Peter Lin has collaborated with scholars based in Australia and Canada. Frequent co-authors include Michael F. Lin, Ivan Ho Shon, Myo Min, Dion F. Forstner, Andrew Mark Scott, Dishan H. Gunawardana, Dylan L. Bartholomeusz, Jayne E. Ramshaw, Victoria Bray and Lois Charlotte Holloway. Their work appears in journals such as British Journal of Radiology, The Lancet Oncology, Radiotherapy and Oncology, European Journal of Nuclear Medicine and Molecular Imaging and Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact